Serametrix provides effective immune monitoring of cancer patients samples to support clinical trials for novel combination and immune-based therapies.
Reveal cancer patient’s immune status
Monitor drug impact on anti-tumor immune response
Advance cancer therapy through immune monitoring
Latest News
Caprion Biosciences Expands its Global Biomarker and Immune Monitoring Franchise by Acquiring Serametrix Corporation
MONTREAL, QUEBEC (April 30, 2019) / CNW Telbec / Caprion Biosciences announced today that the company acquired Serametrix Corporation, a specialized provider of immune monitoring services headquartered in Carlsbad, California. Caprion plans to leverage the proprietary...
Serametrix MDSC Assay Being Utilized By Infinity Pharmaceuticals in the First Clinical Study to Prospectively Identify Patients With High Blood Levels of MDSCs
Serametrix MDSC Assay Being Utilized By Infinity Pharmaceuticals in the First Clinical Study to Prospectively Identify Patients With High Blood Levels of MDSCs First Patient Enrolled in IPI-549 Plus OPDIVO® MDSC-High Cohort in Infinity Pharmaceuticals...
©2019 Serametrix l US: +1-760-652-4060 l Europe: +44 (0)20 8973 3853 | info@serametrix.com